The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

from AcademicCME Podcast · host Patrick Hayes

This activity was supported by an educational grant from Merck & Co., Inc.. Please go to ⁠academiccme.com/EPCPAH and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

Episode metadata supplied by the publisher feed · Published Mar 17, 2025

Embed this episode

Attribution link and audio player

Ready to play

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

0:00 38:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AcademicCME Podcast?

This episode is 38 minutes long.

When was this AcademicCME Podcast episode published?

This episode was published on March 17, 2025.

Can I download this AcademicCME Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!